Carter Robert Ross
SEC CIK 2039341 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| STLN | Starling Oncology, Inc. | CFO | 414.8K | $9,418 | $879.32 | 13 | 2024-11-20 | 2026-05-21 |
Most active insiders at STLN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Chernett Jorey | 10% | $2.69M | — |
| 2 | Hively Brad | Dir | — | $2.00M |
| 3 | Kaushal Mohit | Dir | — | $335.1K |
| 4 | Podnos Yale | Chief Medical Off | — | $276.4K |
| 5 | Pacala Mark L | Dir | — | $200.0K |
| 6 | Carter Robert Ross | CFO | — | $879.32 |
| 7 | England Kristin | Chief Administrative Off | — | — |
| 8 | Langsam Jeffrey | Chief Clinical Off | — | — |
| 9 | Ling Gabriel | Dir | — | — |
| 10 | TOI M, LLC | Dir | — | — |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-22 17:32 | 2026-05-21 | STLN | Starling Oncology, Inc. | Carter Robert Ross | CFO | J - Other | $4.47 | -1,604 | 414.8K | -0.4% | -$7,170 | |
| 2026-04-01 20:47 | 2026-03-27 | STLN | Starling Oncology, Inc. | Carter Robert Ross | CFO | A - Grant | $0.00 | -202.9K | 436.7K | -32% | $0 | |
| 2026-04-01 20:47 | 2026-03-27 | STLN | Starling Oncology, Inc. | Carter Robert Ross | CFO | J - Other | $3.07 | -20.3K | 416.4K | -5% | -$62.4K | |
| 2026-03-18 | 2026-03-17 | STLN | Starling Oncology, Inc. | Carter Robert Ross | CFO | J - Other | $3.59 | -1,314 | 233.8K | -0.6% | -$4,717 | |
| A | 2026-01-06 | 2026-01-02 | STLN | Starling Oncology, Inc. | Carter Robert Ross | CFO | J - Other | $3.67 | -244 | 235.1K | -0.1% | -$895.48 |
| 2026-01-05 | 2026-01-02 | STLN | Starling Oncology, Inc. | Carter Robert Ross | CFO | S - Sale | $3.56 | -247 | 235.1K | -0.1% | -$879.32 | |
| 2025-11-19 | 2025-11-17 | STLN | Starling Oncology, Inc. | Carter Robert Ross | CFO | A - Grant | $0.00 | +195 | 235.4K | +0.1% | $0 | |
| 2025-05-22 | 2025-05-21 | STLN | Starling Oncology, Inc. | Carter Robert Ross | CFO | D - Sale to Iss | $2.68 | -1,601 | 235.2K | -0.7% | -$4,291 | |
| 2025-04-02 | 2025-03-31 | STLN | Starling Oncology, Inc. | Carter Robert Ross | CFO | A - Grant | $0.00 | +197.4K | 236.8K | +501% | $0 | |
| D | 2025-03-28 | 2025-03-26 | STLN | Starling Oncology, Inc. | Carter Robert Ross | CFO | P - Purchase | $1.04 | +9,056 | 39.4K | +30% | +$9,418 |
| 2025-03-20 | 2025-03-19 | STLN | Starling Oncology, Inc. | Carter Robert Ross | CFO | D - Sale to Iss | $0.89 | -1,150 | 30.4K | -4% | -$1,024 | |
| 2025-01-07 | 2025-01-06 | STLN | Starling Oncology, Inc. | Carter Robert Ross | CFO | D - Sale to Iss | $0.34 | -258 | 31.5K | -0.8% | -$87.72 | |
| 2024-11-21 | 2024-11-20 | STLN | Starling Oncology, Inc. | Carter Robert Ross | CFO | D - Sale to Iss | $0.14 | -235 | 31.8K | -0.7% | -$32.90 |
Purchase Sale Sale after option exercise All abbreviations